Advances in topical analgesics : Current Opinion in Anesthesiology (original) (raw)
PAIN MEDICINE: Edited by Honorio T. Benzon
aDepartment of Anesthesia and Critical Care, University of Chicago Medicine
bDepartment of Anesthesiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
cDepartment of Neurology, Albany Medical College, Albany, New York, USA
Correspondence to Magdalena Anitescu, MD, PhD, Department of Anesthesia and Critical Care, University of Chicago Medicine, 5841 S. Maryland Avenue MC-4028, Chicago, IL 60637, USA. Tel: +1 773 834 0891; fax: +1 773 834 2218; e-mail: [email protected]
Abstract
Purpose of review
The recent increase in opioid consumption in the modern world prompted pain physicians to find new and improved solutions to tackle chronic, refractory pain syndromes. Topical analgesics are emerging as a valued multimodal analgesic arm in the fight against chronic pain.
Recent findings
New and improved topical formulations have emerged as effective tools to treat chronic refractory pain. In addition to formulations manufactured by the pharmaceutical industry, there has been a recent interest in mixed topical products by local, regional and national compounding pharmacies. This review will focus on advances in topical analgesics, especially their role as an effective analgesic in nociceptive and neuropathic refractory pain states. We will explore topical analgesics’ mechanisms of action and their efficacy as opioid-sparing formulations.
Summary
This review will allow physicians to understand the role of topical agents in the treatment of intractable pain syndromes. Increasing medical providers’ familiarity with these agents will allow their incorporation as part of a complex analgesic regimen for an improved pain management plan benefiting the patient population at large.
© 2013 Lippincott Williams & Wilkins, Inc.